Room to Run, the Race for a COVID-19 Antibody Drug, and the Most Underappreciated Risk

  • Af
  • Episode
      110
  • Published
      27. maj 2020
  • Forlag
0 Anmeldelser
0
Episode
110 of 1530
Længde
46M
Sprog
Engelsk
Format
Kategori
Økonomi & Business

Another rally on Wall Street and two strategists both say there’s more room to run…where they’re finding opportunities.

The CEO of AbCellera joins to discuss the company’s partnership with Eli Lilly in the race for a COVID-19 antibody drug.

And two policy strategists weigh in one of the biggest and most underappreciated risks for the market right now.

Plus, a ‘cool’ trade for the summer.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036

Other podcasts you might like ...